Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 ...
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Neomorph, Inc., today announced the appointment of Dr. Klaus Wagner as Chief Medical Officer. Dr. Wagner is a seasoned ...
The former and current cops’ supposed violations include the planting of evidence, and the delay and bungling in the ...
Michael Irwin will drive Metabolon's global sales strategy as the company moves into its next phase of growth in the mutliomic marketplace MORRISVILLE, N.C., Jan. 14, 2025 /PRNewswire/ ...
Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experienceSOUTH SAN FRANCISCO, Calif., ...
Over the years, an increasing number of studies have linked formaldehyde to cancers that are especially prevalent among Black ...
Dyne Therapeutics (DYN) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation for DYNE-101 for the ...
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...
The FDA has developed a new strategy to prevent the contamination of fresh and frozen berries with viruses such as hepatitis A and norovirus. “Collaboration between regulators, the global berry ...